Gadolinium-based contrast agents are used in many different types of MRIs. One type includes lumbosacral spine MRIs, which use magnetic resonance imaging to create a images of the structure of the spine, spinal cord, and the vertebrae. 

These images are then used by doctors to diagnose spinal injuries, spinal cancer, or other types of illenesses and injuries. The gadolinium enhances these images so that the doctor can better perform the diagnosis. 

The benefit, however, comes at a cost. The use of gadolinium-based contrast agents in MRIs has been linked to a number of negative side effects. 

If you or anyone you know has suffered negative side effects due to gadolinium exposure, contact the NSF lawyers of Williams Kherkher at 800-761-3187.

Gadolinium is used an MRI contrast agent to enhance MRI images. This enhancement occurs on the chemical level because of its oxidation state. 

In other words, the atomic structure of gadolinium causes water around the contrast agent to settle so that the image can be enhanced. Without this enhancement, the image quality is often poorer. 

If you or anyone you know has experienced negative side effects due to gadolinium, contact the gadolinium lawyers of Williams Kherkher 800-761-3187.

U.S. drug reviewers released a report on Tuesday indicating that the use of some contrast agents is riskier than others. According to the report, people who use these drugs have a better chance of contracting certain skin diseases. 

These drugs include GE Healthcare's Omniscan, Bayer AG's Magnevist and Covidien's Optimark. The Food and Drug Administration linked these drugs to such diseases as nephrogenic systemic fibrosis. 

If you or anyone you know has used these contrast agents, contact the gadolinium lawyers of Williams Kherkher at 800-761-3187. 

Optimark will undergo a voluntarily label change to notify users of the risks associated with the product. According to MSN's Market Report, Covidien announced that it will contraindicate the Optimark gadovesetamide injection. 

The injection is used as a gadolinium-based contrast agent for magnetic resonance imaging procedures. While some label changes are voluntary, gadolinium-based contrast agents have been associated with mandatory label changes in the past to inform patients about the risks. 

If you or anyone you know has suffered negative side effects as a result of being injected with a gadolinium-based contrast agent, contact the NSF and NFD lawyers of Williams Kherkher at 800-761-3187.

When undergoing an MRI, people with kidney problems should exercise care. While not all MRI scans are dangerous for people with kidney problems, MRIs with some contrast agents may pose a serious risk. 

Gadolinium contrast agents pose a risk because they increase the chance of contracting nephrogenic systemic fibrosis (NSF). NSF causes the thickening of the skin, organs, and other tisues. 

If you have kidney problems and suffered serious side effects from a gadolinium-based contrast agent, contact the NSF lawyers of Williams Kherkher at 800-761-3187.